The Liver Lab

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

Nonalcoholic fatty liver disease: A wide spectrum disease

Rosso N, Bellentani S

Chapter of 'Liver Diseases'

Springer book

2020

lcnRNA-mediated regulation of acquired chemoresistance in HCC

DiStefano J, Sukowati CHC

Chapter of ‘The Chemical Biology of Long Noncoding RNAs

Springer book

2020

Heterogeneity of hepatic cancer stem cells

Sukowati CHC

Chapter of 'Stem Cells Heterogeneity in Cancer"

Adv Exp Med Biol 2019, Vol. 1139 (ed: A. Birbrair)
 
Springer Nature

2019

 

A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Riordan SM,  Bittel DC, Le Pichon JP, Gazzin S, Tiribelli C, Watchko JF, Wennberg RP, Shapiro SM

Biology of Brain Disorder

Frontiers Cellular Neuroscience

2018

 

Physiology of the liver

Bellarosa C, Tiribelli C

Handbook of gastroenterology and liver diseases

Minerva Medica

2016

Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Moretti R, Sartori A, Fantini J, Gazzin S

In "Horizons in Neuroscience Research" Volume 18

Nova Science Publishers, Inc

2015

Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Moretti R, Sartori A, Baso B, Gazzin S

In "Alzheimer's Disease - Challenges for the Future" Chapter 11

InTech, DOI: 10.5772/59834, ISBN 978-953-51-2137-4

2015

 

Alcohol and nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, Bedogni G

Nutrition and Health by R.R. Watson et al. (eds.), Springer Science+Business Media New York

2013

Bilirubin metabolism and transport

Bellarosa C, Muchova L,Vitek L, Tiribelli C.

In “Care of the Jaundiced Neonate” by David Stevenson et al(eds), McGraw Hill Companies, Inc.

2012

Disturbances of bilirubin metabolism

Bellarosa C and Tiribelli C

In “Textbook of Clinical Gastroenterology and Hepatology, Second Edition” Wiley Online Library

2012

Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health

Martini D, Galli C, Guareschi C, Angelino D, Bedogni G, Biasini B, Zavaroni I, Pruneti C, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Passeri G, Del Rio D

NFS Journal 10:10-25

2018

Claimed effects, outcome variables and methods of measurement for health claims proposed under regulation (EC) 1924/2006 and related to cognitive function in adults

Martini D, Innocenti A, Cosentino C, Bedogni G, Zavaroni I, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Passeri G, Pruneti C, Del Rio D

Arch Ital Biol. 156(1-2):64-86. doi: 10.12871/00039829201817

2018

 

Methylsulfonylmethane and mobilee prevent negative effect of IL-1β in human chondrocyte cultures via NF-κB signaling pathway

Cheleschi S, Fioravanti A, De Palma A, Corallo C, Franci D, Volpi N, Bedogni G, Giannotti S, Giordano N

International Immunopharmacology 65:129-139

2018

 

Claimed effects, outcome variables and methods of measurement for health claims on foods proposed, under European Community Regulation 1924/2006 in the area of appetite ratings and, weight management

Martini D, Biasini B, Rossi S, Zavaroni I, Bedogni G, Musci M, Pruneti C, Passeri G, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna R, Del Rio D

Int J Food Sci Nutr. 69(4):389-409. doi: 10.1080/09637486.2017.1366433

2018

 

Neuro-inflammatory effects of photodegradative products of bilirubin

Jašprová J, Dal Ben M, Hurný D, Hwang S, Žížalová K, Kotek J, Wong RJ, Stevenson DK, Gazzin S, Tiribelli C, Vítek L

Sci Rep. 8(1):7444. doi: 10.1038/s41598-018-25684-2

2018

 

Resting energy expenditure in children with cerebral palsy: Accuracy of available prediction formulae and development of a population-specific formula

Penagini F, Borsani B, Bosetti A, Mameli C, Dilillo D, Ramponi G, Motta F, Bedogni G, Zuccotti GV

Clin Nutr ESPEN. 25:44-49. doi: 10.1016/j.clnesp.2018.04.006

2018

 

Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health

Martini D, Guareschi C, Biasini B, Bedogni G, Galli C, Angelino D, Marchi L, Zavaroni I, Pruneti C, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Passeri G, Del Rio D

PharmaNutrition 6:17-36

2018

Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations

Martini D, Biasini B, Zavaroni I, Bedogni G, Musci M, Pruneti C, Passeri G, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Del Rio D

Acta Diabetol. 55(4):391-404. doi: 10.1007/s00592-017-1095-6

2018

 

Management of restless legs syndrome in chronic liver disease: A challenge for the correct diagnosis and therapy

Moretti R, Caruso P, Tecchiolli M, Gazzin S, Tiribelli C

World J Hepatol. 10(3): 379-387

2018

 

Gut microbiota characterisation in obese patients before and after bariatric surgery

Campisciano G, Palmisano S, Cason C, Giuricin M, Silvestri M, Guerra M, Macor D, De Manzini N, Crocé LS, Comar M                                                                                                                             

Benef Microbes. Feb 27:1-8. doi: 10.3920/BM2017.0152.

2018

 

Transcutaneous bilirubin measurements: useful, but also reproducible?

Dani C, Hulzebos CV, Tiribelli C

Pediatr Res. 2020. doi: 10.1038/s41390-020-01242-3.

2020

Elastography: where are we now?

Giuffré M, Colecchia A, Crocé LS

Minerva Gastroenterol Dietol. 2020. doi: 10.23736/S1121-421X.20.02773-7.

2020

The role of bilirubin and other “yellow players” in neurodegenerative diseases

Jayanti S, Vitek L, Tiribelli C, Gazzin S

Antioxidants. 9(9):900. doi: 10.3390/antiox9090900.

2020

Bilirubin, Intestinal Integrity, the Microbiome, and Inflammation

Vítek L, Tiribelli C

N Engl J Med 2020 Aug 13;383(7):684-686.doi: 10.1056/NEJMcibr2013250.

2020

HCC occurrence after DAA treatments: Molecular tools to assess the post-treatment risk and surveillance

Pascut D, Pratama MY, Tiribelli C

Hepat Oncol. 2020 Jun 22;7(2):HEP21. doi: 10.2217/hep-2020-0010

2020

Sorafenib resistance in hepatocellular carcinoma: The relevance of genetic heterogeneity

Cabral KL, Tiribelli C, Sukowati CHC

Cancers (Basel). 2020 Jun 15;12(6):E1576. doi: 10.3390/cancers12061576.

2020

Charles E. Ahlfors (1944–2020)

Wennberg RP, Wong RJ, Shapiro SM, Tiribelli C

Pediatr Res. 2020 May 6. doi: 10.1038/s41390-020-0938-y.

2020

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

Eslam M, Sanyal AJ, George J, on behalf of an international consensus panel (including Tiribelli C)    

Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312.

2020

A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature

Giuffrè M, Campigotto M, Campisciano G, Comar M, Crocè LS

Am J Physiol Gastrointest Liver Physiol.318(5):G889-G906 doi: 101152/ajpgi001612019

2020

Sex differences in Non-Alcoholic Fatty Liver Disease: Hints for future management of the disease

Salvoza NC, Giraudi PJ, Tiribelli C, Rosso N

Explor Med. 2020;1:51-74 DOI: https://doi.org/10.37349/emed.2020.00005

2020